Drooid Logo
Back to today’s briefing

Story perspectives

GLP-1 Drugs: Promise and Peril in Kentucky's Obesity Crisis

1/28/2025

45 8

1 of 2

GLP-1 Drugs' Duality
  • A study from Washington University reveals the dual nature of GLP-1 drugs like Ozempic and Wegovy in Kentucky, a state grappling with high obesity rates. While these medications may enhance cognitive health and curb addiction, they also carry potential dangers, including pancreatitis and kidney problems. More research is essential to fully understand their effects.
1 / 2